Home/Filings/4/0001140361-23-019676
4//SEC Filing

Benton Susan 4

Accession 0001140361-23-019676

CIK 0001228627other

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 8:20 PM ET

Size

5.0 KB

Accession

0001140361-23-019676

Insider Transaction Report

Form 4
Period: 2023-04-19
Benton Susan
Director
Transactions
  • Award

    Common Stock

    2023-04-19+1,05368,486 total
Footnotes (1)
  • [F1]The Reporting Person was granted shares of common stock in lieu of incremental cash amounts for board services for 2023. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $4.27 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to April 19, 2023.

Documents

1 file

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001373649

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 8:20 PM ET
Size
5.0 KB